Table 4.

Changes in BA Pool Size in Patients With CD

StudyRutgeerts et al50Nishida et al52Rutgeerts et al46Vantrappen et al51
SampleDDDD
Disease locationL1L3/L2/
Total BA pool
CDCA pool
UDCA pool
StudyRutgeerts et al50Nishida et al52Rutgeerts et al46Vantrappen et al51
SampleDDDD
Disease locationL1L3/L2/
Total BA pool
CDCA pool
UDCA pool

Only BA pools for which at least 2 studies reported alterations are displayed.

↑ = higher level in patients with CD compared with HCs; ↓ = lower level in patients with CD compared with HCs; / = no information available. Empty boxes indicate that no significant difference or no information was provided in the studies.

D indicates fasting duodenal bile; BA, bile acid; CDCA, chenodeoxycholic acid; L1/L2/L3, terminal ileitis/colitis/ileocolitis; UDCA, ursodeoxycholic acid.

Table 4.

Changes in BA Pool Size in Patients With CD

StudyRutgeerts et al50Nishida et al52Rutgeerts et al46Vantrappen et al51
SampleDDDD
Disease locationL1L3/L2/
Total BA pool
CDCA pool
UDCA pool
StudyRutgeerts et al50Nishida et al52Rutgeerts et al46Vantrappen et al51
SampleDDDD
Disease locationL1L3/L2/
Total BA pool
CDCA pool
UDCA pool

Only BA pools for which at least 2 studies reported alterations are displayed.

↑ = higher level in patients with CD compared with HCs; ↓ = lower level in patients with CD compared with HCs; / = no information available. Empty boxes indicate that no significant difference or no information was provided in the studies.

D indicates fasting duodenal bile; BA, bile acid; CDCA, chenodeoxycholic acid; L1/L2/L3, terminal ileitis/colitis/ileocolitis; UDCA, ursodeoxycholic acid.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close